The global Aarskog-Scott Syndrome Treatment industry is entering a period of significant scientific and clinical advancement, driven by rising research investment, progress in genetic diagnostics, and improved access to advanced therapeutics. According to Data Bridge Market Research, the global market—valued at USD 3.01 billion in 2022—is projected to...